Estrogen's impact on cognitive functions in multiple sclerosis

International Journal of Neuroscience

Volumn 86, Issue 1-2, 1996, Pages 23-31

  Sandyk, Reuven ^a,b,c  

^a NeuroCommunication Res Laboratories   (United States)

^b TOURO COLLEGE   (United States)

^c NONE   (United States)

Author keywords

5 HT2 receptors; cognitive functions; estrogens; frontal cortex; Multiple sclerosis; serotonin (5 HT)

Indexed keywords

EID: 0030186102     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459608986695     Document Type: Article

References (99)

1. Abramsky, O. (1994). Pregnancy and multiple sclerosis Annals of Neurology, (suppl), 36, S38-S43.
2. Aghajanian, G. K., Sprouse, J. S. and Rasmussen, K. (1987). Physiology of the midbrain serotonin system. In H.Y. Meltzer (Ed.), Psychopharmacology, the third generation of progress (pp. 141-149) New York: Raven Press
3. Altar, C. A., O'Neill, S. and Walter, R. W. (1985). Brain dopamine and 5-HT receptor sites revealed by digital substraction autoradiography. Science, 228, 597-600.
4. Altman, H. J. and Normile, H. J. (1986). Enhancement of the memory of a previously learned aversive habit following pre-test administration of a variety of serotonergic antagonists in mice. Psychopharmacology, 90, 24-27.
5. Altman, H. J. and Normile, H. J. (1988). What is the nature of the role of the serotonergic nervous system in learning and memory: prospects for development of an effective treatment strategy for senile dementia. Neurobiology of Aging, 9, 627-638.
6. Archer, T., Ogren, S. O. and Johansson, C. (1981). The acute effects of p-chloroamphetamine on the retention of fear conditioning in the rat evidence for a role of serotonin in memory consolidation. Neuroscience Letters, 25, 75-81.
7. Baumgarten, H. G. and Lachenmayer, L. (1985) Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatrie, 18, 180-187.
8. Beatty, W. W., Goodkin, D. E., Beatty, P. A. & Monson, N. (1989). Frontal lobe dysfunction and memory impairment in patients with chronic progressive multiple sclerosis. Brain and Cognition, 11, 73-86.
9. Bedard, P. and Pycock, C. J. (1977). 'Wet dog' shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology, 16, 663-670.
10. Benton, A. L. (1968). Differential effects of frontal lobe disease. Neuropsychologia, 6, 53-60.
11. Biegon, A., Bercovitz, H. and Samuel, D. (1980). Serotonin receptors concentration during the estrous cycle of the rat. Brain Research, 187, 221-225
12. Biegon, A., Reches, A., Snyder, L. and McEwen, B. (1983). Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sciences, 32, 2015-2021.
13. Birk, K. and Rudick, R. (1986). Pregnancy and multiple sclerosis. Archives of Neurology, 43, 719-726.
14. Birk, K , Ford, C., Smeltzer, S., Ryan, D., Miller, R and Rudick, R. A. (1990). The clinical course of multiple sclerosis during pregnancy and the puerperium. Archives of Neurology, 47, 738-742.
15. Birner, I. M. (1945). Pregnancy and multiple sclerosis: case report. New York State Journal of Medicine, 45, 634-635.
16. Brunello, N., Riva, M., Rovescalli, A. C , Galimberti, R. and Racasni, G. (1988). Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment. Pharmacology and Toxicology, 63, 150-155.
17. Chopin, P. and Briley, M. (1987). Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission. Trends in Pharmacological Sciences, 8, 383-388.
18. Claveria, L. E., Curzon, G., Harrison, M. J. G. and Kantamaneni, B. D. (1974). Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 37, 715-718.
19. Comings, D. E. (1990). Tourette syndrome and human behavior (pp. 341-361) Duarte, CA: Hope Press.
20. Costall, B., Domeney, A.M., Kelly, M. E. and Naylor, R. J. (1992). Influence of 5-HT on cognitive performance. In. P. B. Bradley, S. L. Handley, S. J. Cooper, B. J. Key, N. M. Barnes and J. H Coote (Eds), Serotonin, CNS receptors and brain function (pp. 147-164). Oxford: Pergamon Press.
21. Cowen, P. J. (1991). Serotonin receptor subtypes: implications for psychopharmacology. British Journal of Psychiatry, 159 (suppl 12), 7-14.
22. Cross, A. J., Crow, T. J., Ferrier, I. N., Johnson, J. A., Bloom, S. R. and Corsellis, J. A. N. (1984). Serotonin receptor changes in dementia of the Alzheimer's type. Journal of Neurochemistry, 43, 1574-1581.
23. Davidson, D., Pullar, I. A., Mawdsley, C., Kinloch, N. and Yates, C. M. (1977). Monoamine metabolites in cerebrospinal fluid in multiple sclerosis Journal of Neurology, Neurosurgery, and Psychiatry, 40, 741-745.
24. Davis, R. K. and Maslow, A. S. (1992). Multiple sclerosis in pregnancy: a review. Obstetrics and Gynecological Survey, 47, 290-296.
25. Dickey, R. P. and Stone, S. C. (1978). Gonadal hormones and cognitive performance. Physiological Psychology, 6, 115-120.
26. 2 receptor mechanism plays a key role in the proestrous surge of luteinizing hormone in the rat. Psychoneuroendocrinology, 19, 395-399.
27. Duquette, P. and Girard, M. (1993). Hormonal factors in susceptibility to multiple sclerosis. Current Opinion in Neurology and Neurosurgery, 6, 195-201.
28. Duquette, P., Pleines, J , Charest, L., Senecal-Quevillon, M and Masse, C. (1992). The increased susceptibility of women to multiple sclerosis. Canadian Journal of Neurological Sciences, 19, 466-471.
29. Eisen, A. S., Eisen, M. S., Torrente, J. R., Wright, R. N. and Yocca, F. D (1990). Nefazodone: preclinical pharmacology of a new antidepressant. Psychopharmacology Bulletin, 26, 311-315.
30. Fahn, S (1979). Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen. Advances in Neurology, 26, 49-84.
31. Fischette, C. T., Biegon, A. and McEwen, B. S. (1983). Sex differences in serotonin-1-receptor binding in rat brain. Science, 222, 333-335.
32. Fischman, H R. (1981). Multiple sclerosis: a two stage process? American Journal of Epidemiology, 114, 244-252.
33. Francis, G. S , Antel, J. P. and Duquette, P. (1990). Inflammatory demyelinating diseases of the CNS. In W. G. Bradley, B. Daroff, G. M. Fenichel & C. D. Marsden (Eds.), Neurology in clinical practice (p. 1154). Boston: Butterworth
34. Franklin, G. M., Nelson, L. M., Filley, C. M. and Heaton, R. K. (1989) Cognitive loss in multiple sclerosis. Case reports and review of the literature. Archives of Neurology, 46, 162-167.
35. Freeman, E. W., Rickels, K., Sondheimer, S. J., Denis, A., Pfeifer, S. and Weil, S. (1994). Nefazodone in the treatment of premenstrual syndrome: a preliminary study. Journal of Clinical Psychopharmacology, 14, 180-186.
36. Ghezzi, A. and Caputo, D. (1981). Pregnancy: a factor influencing the course of multiple sclerosis? European Neurology, 20, 115-117.
37. Glennon, R. A. (1990). Serotonin receptors: clinical implications. Neuroscience and Biobehavioral Reviews, 14, 35-47.
38. 2 receptors of the human brain postmortem. Brain Research, 519, 223-227.
39. Hampson, E (1990). Estrogen-related variations in human spatial and articulatory-motor skills. Psychoneuroendocrinology, 15, 97-111.
40. Harris, B. (1994). Biological and hormonal aspects of postpartum depressed mood. Working towards strategies for prophylaxis and treatment. British Journal of Psychiatry, 164, 288-292
41. Heaton, R. K., Nelson, L. M., Thompson, D. S., Burks, J. S and Franklin, G. M. (1985). Neuropsychological findings in relapsing remitting and chronic progressive multiple sclerosis. Journal of Consulting and Clinical Psychology, 53, 103-110.
42. Johansson, B. and Ross, B. E. (1977). 5-hydroxyindoleacetic acid and homovanillic acid in CSF of patients with neurological disease. European Neurology, 11, 37-45.
43. Junquiera, L. C. and Carneiro, J. (1983). Basic histology, 4th ed. Los Altos, CA. Lange Medical Publications.
44. Kendall, D. A., Stancel, G M. and Enna, S J. (1981) Imiprarnine: effect of ovarian steroids on modifications in serotonin receptor binding. Science, 211, 1183-1185.
45. Korn-Lubetzki, I., Kahana, E , Cooper, G. and Abramsky, O. (1984). Activity of multiple sclerosis during pregnancy and puerperium. Annals of Neurology, 16, 229-231.
46. Kueng, W., Wirz-Justice, A., Menzi, R. and Chappuis-Arndt, E. (1976) Regional brain variations of tryptophan, monoamines, monoamine oxidase activity, plasma free and total tryptophan during the estrous cycle of the rat. Neuroendocrinology, 21, 289-296
47. Lawlor, B. A. (1990). Serotonin and Alzheimer's disease. Psychiatric Annals, 20, 567-570
48. Leonard, B. E. (1988). Pharmacological effects of serotonin reuptake inhibitors. Journal of Clinical Psychiatry, 49, (suppl), 12-17.
49. Leysen, J. (1983). Serotonin receptor binding sites: Is there pharmacological and clinical significance? Medical Biology, 61, 139-143.
50. Leysen, J. E. (1985). Characterization of serotonin receptor binding sites. In A. R Green (Ed.), Neuropharmacology of serotonin (pp. 79-116). Oxford: Oxford University Press.
51. Luga, N. and Hategan, D. (1986). Determination of serotonin content and ceruloplasmin activity of blood and CSF amino acid level in multiple sclerosis. Review Roumanian Medicine - Neurology and Psychiatry, 24, 153-159.
52. Magos, A. and Studd, J. (1985). Effects of the menstrual cycle on medical disorders. British Journal of Hospital Medicine, 33, 68-77.
53. Markianos, M. and Sfagos, C. (1988) Altered serotonin uptake kinetics in multiple sclerosis. Journal of Neurology, 235, 236-237.
54. Mayeux, R., Stern, Y., Sano, M., Williams, J. B. W. and Cote, L. J. (1988). The relationship of serotonin to depression in Parkinson's disease. Movement Disorders, 3, 237-244.
55. McCall, M., Sutherland, J. and Acheson, E. (1969) The frequency of multiple sclerosis in Western Australia. Acta Neurologica Scandinavica, 45, 151-165.
56. McEntee, W. J. and Crook, T. H (1991). Serotonin, memory, and the aging brain. Psychopharmacology, 103, 143-149
57. McEntee, W. J. and Mair, R. G. (1980). Memory enhancement in Korsakoff's psychosis with clonidine: further evidence for a noradrenergic deficit. Annals of Neurology, 7, 466-470.
58. Mesulam, M. M. (1986). Frontal cortex and behavior. Annals of Neurology, 19, 320-325.
59. Millar, J. H. D., Allison, R. S., Cheeseman, E. A. and Merrett, J. D. (1959). Pregnancy as a factor influencing relapse in disseminated sclerosis Brain, 82, 417-426.
60. Monaco, F., Fumero, S., Mondino, A. and Mutani, R. (1979). Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology, Neurosurgery and Psychiatry, 42, 640-641.
61. 2 receptors in the rat brain. Neuroscience, 54, 701-717.
62. Munaro, N. I. (1978). The effect of ovarian steroids on hypothalamic 5-hydroxytryptamine neuronal activity. Neuroendocrinology, 26, 270-276.
63. Nilsson, O. G., Strecker, R. E., Daszuta, A. and Bjorklund, A. (1988). Combined cholinergic and serotonergic denervation of forebrain produces severe deficits in a spatial learning task in the rat. Brain Research, 453, 235-246.
64. O'Connor, L. H. and Feder, H H. (1984). Estradiol and progesterone influence a serotonin mediated behavioral syndrome (myoclonus) in female guinea pigs: comparison with steroid effects on reproductive behavior. Brain Research, 293, 119-125.
65. Pazos, A., Cortes, R. and Palacios, J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. serotonin-2-receptors. Brain Research, 346, 231-249.
66. Peroutka, S. J., Lebovitz, R. M. & Snyder, S. H. (1981). Two distinct central serotonin receptors with different physiological functions. Science, 212, 827-829.
67. Peroutka, S. J., Sleight, A. J , McCarthy, B. G., Pierce, P. A., Schmidt, A. W. and Hekmatpanah, C. R. (1989). The clinical utility of pharmacological agents that act at serotonin receptors. Journal of Neuropsychiatry, 1, 253-262
68. Peyser, J. M., Rao, S. M., LaRocca, N. G. and Kaplan, E. (1990). Guidelines for neuropsychological research in multiple sclerosis. Archives of Neurology, 47, 94-97.
69. Poser, S. and Poser, W. (1983). Multiple sclerosis and gestation. Neurology, 33, 1422-1427.
70. Pranzatelli, M. and Snodgrass, S. (1985). The pharmacology of myoclonus. Clinical Neuropharmacology, 8, 99-130.
71. Rao, S. M., Hammeke, T. A., McQuillen, M. P., Khatri, B. O. and Lloyd, D. (1984). Memory disturbance in chronic progressive multiple sclerosis. Archives of Neurology, 41, 625-631.
72. Rao, S. M., Hammeke, T. A. and Speech, T. J. (1987). Wisconsin Card Sorting Test performance in relapsing-remitting and chronic progressive multiple sclerosis. Journal of Consulting and Clinical Psychology, 55, 263-265.
73. Rao, S. M., Leo, G. J., Bernardin, L. and Unverzagt, F. (1991). Cognitive dysfunction in multiple sclerosis I Frequency, patterns, and prediction. Neurology, 41, 685-691.
74. Richter-Levin, G and Segal, M. (1988). Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission. Brain Research, 477, 404-407
75. Rose, D. P. (1967). The influence of sex, age and breast cancer on tryptophan metabolism. Clinica Chimica Acta, 18, 221-215.
76. Sampson, E. and Kimura, D. (1988). Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behavioral Neuroscience, 102, 456-459.
77. Sandyk, R (1995). Premenstrual exacerbation of symptoms in multiple sclerosis is attenuated by treatment with weak electromagnetic fields. International Journal of Neuroscience, 83, 187-198.
78. Schapira, K., Poskanzer, D. C., Newell, D. J. and Miller, H. (1966). Marriage, pregnancy and multiple sclerosis. Brain, 89, 419-428.
79. 2 receptors in human brain Brain Research, 276, 231-235.
80. 2-activated interneuron. Brain Research, 506, 62-69.
81. Sirvio, J., Riekkinen, P., Jakala, P. and Riekkinen, P. J. (1994). Experimental studies on the role of serotonin in cognition. Progress in Neurobiology, 43, 363-379.
82. Soininen, H., MacDonald, E., Rekonen, M. and Riekkinen, P. J. (1981). Homovanillic acid and 5-hydroxyin-doleacetic acid in cerebrospinal fluid of patients with senile dementia of the Alzheimer type. Acta Neurologica Scandinavica, 64, 101-107.
83. Sonninen, V., Riekkinen, P. and Rinne, U. K. (1973). Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology, 23, 760-763.
84. Stanley, M. and Mann, J. J. (1983). Increased serotonin-S2 binding sites in frontal cortex of suicide victims. Lancet, 1, 214-216.
85. Strek, K. F., Spencer, K. R. and DeNoble, V. J. (1989). Manipulation of serotonin protects against an hypoxia-induced deficit of a passive avoidance response in rats. Pharmacology Biochemistry and Behavior, 33, 241-244.
86. Sumner, B. E. H. and Fink, G. (1993). Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Molecular Cell Neuroscience, 4, 83-92.
87. 2A receptors in the cerebral cortex and nucleus accumbens in the female rat. Journal of Steroid Biochemistry and Molecular Biology, 54, 15-20.
88. Sweeney, W. J. (1955). Pregnancy and multiple sclerosis. American Journal of Obstetrics and Gynecology, 66, 124-130.
89. Tabaddor, K., Wolfson, L. I. and Sharpless, N. S. (1978). Ventricular fluid homovanillic acid and 5-hydroxyin-doleacetic acid concentrations in patients with movement disorders. Neurology, 28, 1249-1253.
90. Tillman, A. J. B. (1950). The effect of pregnancy on multiple sclerosis and its management. Research Publications of the Association for Research in Nervous and Mental Disease, 28, 548-582.
91. Wainerdi, H. R. (1961). Does the multiple-sclerosis syndrome begin at puberty? Boston Medical Quarterly, 12, 44-47.
92. 2 receptors of normal human brain in vitro. European Journal of Pharmacology, 132, 114-121.
93. Ward, M. M., Stone, S. C. and Sandman, C. A. (1978). Visual perception in women during the menstrual cycle Physiology and Behavior, 20, 239-243.
94. Weingartner, H., Rudorfer, M. V., Buchsbaum, M. S. and Linnoila, M. (1983). Effects of serotonin on memory impairments produced by ethanol. Science, 221, 472-474.
95. Wetzel, W., Getsova, V. M., Jork, R. and Matthies, H. (1980). Effect of serotonin on Y-maze retention and hippocampal protein synthesis in rats. Pharmacology Biochemistry and Behavior, 12, 319-322.
96. White, R. F. (1990). Emotional and cognitive correlates of multiple sclerosis. Journal of Neuropsychiatry, 2, 422-428.
97. Whitham, R. H. (1994). Cognitive and emotional disorders in multiple sclerosis. In R. M. Herndon and F. J. Seil (Eds.), Multiple sclerosis: current status of research and treatment (pp. 189-209). New York: Demos.
98. Wirz-Justice, A. and Chappuis-Arndt, E. (1976). Sex specific differences in chlorimipramine inhibition of serotonin uptake in human platelets. European Journal of Pharmacology, 40, 21-25.
99. Woolley, D. E. and Timiras, P. S. (1962). The gonadal brain relationship: effects of female sex hormones on electroshock convulsions in the rat. Endocrinology, 70, 196-209.